The pair have been found to have exploited a loophole by de-branding phenytoin sodium capsules – formerly known as Epanutin - so they were no longer subject to price regulations. Pfizer hiked ...

Pfizer sold its rights to market phenytoin sodium anti-epilepsy drugs under the brand name Epanutin in Britain to Flynn four years ago. Flynn was then able to exploit a “debranding” loophole to ...